Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Hamada

Showing results (271-280 of 328) with videos related to

Pageof 33
Sort By:
Gastrointestinal Endoscopy|January 10, 2025
Quadrant, necrosis, and infection criteria for the risk stratification of walled-off necrosis: external validation using multi-institutional dataHideyuki Shiomi, Tomotaka Saito, Tsuyoshi Hamada, et al.
The Journal of Pathology. Clinical Research|June 9, 2023
Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expressionYohei Masugi, Manabu Takamatsu, Mariko Tanaka, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|September 13, 2023
Risk factors for adverse outcomes at various phases of endoscopic ultrasound-guided treatment of pancreatic fluid collections: Data from a multi-institutional consortiumTomotaka Saito, Shunsuke Omoto, Mamoru Takenaka, et al.
Pancreas|June 1, 2018
A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic CancerTomotaka Saito, Yousuke Nakai, Hiroyuki Isayama, et al.
Cancer Science|May 14, 2022
KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancerTatsunori Suzuki, Yohei Masugi, Yosuke Inoue, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2021
ABO Blood Group and Risk of Pancreatic Carcinogenesis in Intraductal Papillary Mucinous NeoplasmsTsuyoshi Hamada, Hiroki Oyama, Yousuke Nakai, et al.
Gastrointestinal Endoscopy|July 29, 2011
Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancerTsuyoshi Hamada, Hiroyuki Isayama, Yousuke Nakai, et al.
Igie : Innovation, Investigation and Insights|February 6, 2026
Artificial intelligence-based skeletal muscle estimates and outcomes of EUS-guided treatment of pancreatic fluid collectionsMamoru Takenaka, Wataru Gonoi, Tatsuya Sato, et al.
Plos Computational Biology|February 18, 2025
Tumor-immune partitioning and clustering algorithm for identifying tumor-immune cell spatial interaction signatures within the tumor microenvironmentMai Chan Lau, Jennifer Borowsky, Juha P Väyrynen, et al.
Gastrointestinal Endoscopy|August 6, 2013
Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trialRie Uchino, Hiroyuki Isayama, Takeshi Tsujino, et al.
Pageof 33

Showing results (271-280 of 328) with videos related to

Sort By:
Pageof 33
Gastrointestinal Endoscopy|January 10, 2025
Quadrant, necrosis, and infection criteria for the risk stratification of walled-off necrosis: external validation using multi-institutional dataHideyuki Shiomi, Tomotaka Saito, Tsuyoshi Hamada, et al.
The Journal of Pathology. Clinical Research|June 9, 2023
Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expressionYohei Masugi, Manabu Takamatsu, Mariko Tanaka, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|September 13, 2023
Risk factors for adverse outcomes at various phases of endoscopic ultrasound-guided treatment of pancreatic fluid collections: Data from a multi-institutional consortiumTomotaka Saito, Shunsuke Omoto, Mamoru Takenaka, et al.
Pancreas|June 1, 2018
A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic CancerTomotaka Saito, Yousuke Nakai, Hiroyuki Isayama, et al.
Cancer Science|May 14, 2022
KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancerTatsunori Suzuki, Yohei Masugi, Yosuke Inoue, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2021
ABO Blood Group and Risk of Pancreatic Carcinogenesis in Intraductal Papillary Mucinous NeoplasmsTsuyoshi Hamada, Hiroki Oyama, Yousuke Nakai, et al.
Gastrointestinal Endoscopy|July 29, 2011
Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancerTsuyoshi Hamada, Hiroyuki Isayama, Yousuke Nakai, et al.
Igie : Innovation, Investigation and Insights|February 6, 2026
Artificial intelligence-based skeletal muscle estimates and outcomes of EUS-guided treatment of pancreatic fluid collectionsMamoru Takenaka, Wataru Gonoi, Tatsuya Sato, et al.
Plos Computational Biology|February 18, 2025
Tumor-immune partitioning and clustering algorithm for identifying tumor-immune cell spatial interaction signatures within the tumor microenvironmentMai Chan Lau, Jennifer Borowsky, Juha P Väyrynen, et al.
Gastrointestinal Endoscopy|August 6, 2013
Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trialRie Uchino, Hiroyuki Isayama, Takeshi Tsujino, et al.
Pageof 33